15 March 2024
Victrex
plc - Directorate
change
Victrex
appoints Urmi Prasad Richardson as a non-executive
director
Victrex plc is an innovative world
leader in high performance polymer solutions, delivering
sustainable products which enable environmental and societal
benefit in multiple end-markets. The Group
is pleased to announce that Urmi Prasad Richardson has been
appointed as a non-executive director of the Board, effective from
1st May 2024.
Commenting on the
appointment:
Dr Vivienne Cox DBE, Chair of
Victrex, said: "I am delighted to welcome Urmi to the Victrex
Board. She brings a wealth of relevant experience across a number
of global companies, with an emphasis on medical, science-based
innovation, clinical scalability and healthcare. Medical is a key
part of the Victrex Group and one where we have made good progress
in starting to unlock its true potential. Our products support
improved clinical outcomes and our goal is to double revenues in
our Medical business over the next five years.
"Victrex has faced challenging
trading conditions over the past year, in line with the wider
Chemical sector. However, with a wealth of growth opportunities,
high levels of innovation and well invested assets, the Board
remains focused on the delivery of our strategy."
Career history:
Urmi has a wealth of global
experience in executive and non-executive roles over a 25 year
period. She has a particular focus on science, medical and
innovation based businesses. Urmi is currently President EMEA of
Thermo Fisher Scientific, a world leader in serving science, with
products which help accelerate life science research and improve
patient health. Her executive career includes roles at The Linde
Group, where she was Global Head of Healthcare, at Novartis and
Foundation Medicine (a Roche company). She started her career with
G.D. Searle (a Pfizer company) and has worked throughout Europe and
the US. Urmi has extensive experience in strategy, business
development and product commercialisation in Europe, Asia and North
America.
Urmi holds a number of advisory
Board roles at unlisted organisations in the sectors of longevity,
blockchain, and targeted therapy in oncology. Her previous
non-executive roles include Linde Healthcare.
There is no further information to
be disclosed under Listing Rule 9.6.13.
Victrex plc:
Andrew Hanson, Director of Investor
Relations, Corporate Communications & ESG
+44 (0) 1253 898121
+44 (0) 7809 595831
About Victrex:
Victrex is an innovative world
leader in high performance polymer solutions, focused on the
strategic markets of Automotive, Aerospace, Energy &
Industrial, Electronics and Medical. Every day, millions of people
rely on products or applications which contain our sustainable
materials, from smartphones, aeroplanes and cars to energy
operations and medical devices. 'Polymer & Parts' - with over
40 years' experience, we are moving beyond the polymer into
semi-finished and finished products which shape future performance
for our customers and our markets, enable environmental and
societal benefit for our customers and drive value for our
shareholders. Find out more at www.victrexplc.com